Cleared Traditional

K152415 - Digital Blood Pressure Monitor

K152415 is the FDA 510(k) clearance for Digital Blood Pressure Monitor by Suzhou Sunspirit Co., Ltd.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 254-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2016
Decision
254d
Days
Class 2
Risk

K152415 is an FDA 510(k) clearance for the Digital Blood Pressure Monitor. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Suzhou Sunspirit Co., Ltd. (Suzhou, CN). The FDA issued a Cleared decision on May 6, 2016 after a review of 254 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Suzhou Sunspirit Co., Ltd. devices

Submission Details

510(k) Number K152415 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 26, 2015
Decision Date May 06, 2016
Days to Decision 254 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
129d slower than avg
Panel avg: 125d · This submission: 254d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 501
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K152415.
Full Automatic (NIBP) Blood Pressure Monitor
K160557 · Health & Life Co., Ltd. · Jul 2016
Full Automatic (NIBP) Blood Pressure Monitor
K161156 · Health & Life Co., Ltd. · Jun 2016
EV1000 Clinical Platform with ClearSight Finger Cuff or ClearSight System, EV1000 Clinical Platform
K160552 · Edwards Lifesciences, LLC · Jun 2016
Full Automatic (NIBP) Blood Pressure Monitor
K160336 · Health & Life Co., Ltd. · Mar 2016
Full Automatic (NIBP) Blood Pressure Monitor
K160145 · Health & Life Co., Ltd. · Mar 2016
Microlife Upper Arm Automatic Digital Blood Pressure Monitor
K153077 · Microlife Intellectual Property GmbH · Feb 2016